Wang, Dongke
Zhou, Dan
Liu, Xinghuang
Xu, Zhiyue
Bai, Tao http://orcid.org/0000-0001-9697-8510
Hou, Xiaohua
Article History
Received: 25 June 2023
Accepted: 27 October 2023
First Online: 1 December 2023
Declarations
:
: The protocol has been approved by the Ethics Committee of the Wuhan Union Hospital of Huazhong University of Science and Technology (approval number: [2022]0797-01). The trial will follow the Declaration of Helsinki and Good Clinical Practice standards. The patient informed consent form contains the trial process and the possible benefits and risks. No biological samples will be collected in this trial. The investigators will initiate the study with the patient after they have signed the informed consent form. If essential modifications are made to the study protocol, we will submit it to the Ethics Committee for reexamination.
: Not applicable.
: The authors declare that they have no competing interests.